Introduction of AER Bill in U.S. Senate Announced

Introduction of AER Bill in U.S. Senate Announced A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products Company has received a license to manufacture under the Natural Health Products (NHP) certification program of Canada. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. FWS Restores 5-Year Minimum Age for Exported American Ginseng The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). FWS Restores 5-Year Minimum Age for Exported American Ginseng The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). CRN Applauds Senators On AER Bill Introduction CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them. CRN Applauds Senators On AER Bill Introduction CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].” FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].” Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Public Comment Sought on Mandatory Folic Acid Fortification The Australia and New Zealand Food Regulation Ministerial Council asked FSANZ to consider developing a food standard for the mandatory fortification of food with folic acid. A draft standard recommending that folic acid be added to flour used for bread making is now available for public comment. Public Comment Sought on Mandatory Folic Acid Fortification The Australia and New Zealand Food Regulation Ministerial Council asked FSANZ to consider developing a food standard for the mandatory fortification of food with folic acid. A draft standard recommending that folic acid be added to flour used for bread making is now available for public comment. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada. POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada. POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada. FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement FDA is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON, products that are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, as they are illegal drugs that contain potentially harmful undeclared ingredients. FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement FDA is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON, products that are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, as they are illegal drugs that contain potentially harmful undeclared ingredients. UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	(Silver Spring, MD, June 21, 2006) -- A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act, supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days. “The Board of the American Herbal Products Association adopted a position in October 2002 calling for a regulatory change to mandate that serious adverse event reports associated with supplements be forwarded to FDA,” commented Michael McGuffin, AHPA president. “AHPA communicated its decision to Senators Hatch, Durbin and Harkin at that time, and has worked closely with their offices to reach this important goal.” The legislation as introduced will also assure the companies that file reports that any submission they make to FDA will not constitute an admission that their products caused or contributed to the reported event, and that the privacy of individuals will be protected to prevent any misuse of the system. “Dietary supplements as a class have a remarkable safety record,” added McGuffin. “The many Americans who use them responsibly can continue to exercise their freedom of choice, knowing that the rare problems that might be reported will generate the signals that are needed to inform FDA. And marketers of these products can be certain that they will be provided with the same kinds of protection that the pharmaceutical industry enjoys, so that this system does not penalize companies that comply.” Several other trade groups that represent manufacturers of dietary supplements and OTC drugs have also expressed their support of this legislation. “AHPA is pleased that so many of our colleagues have joined us to move this bill forward,” added McGuffin. The bill has been assigned a number: S. 3546. AHPA will provide a link to the text of the bill when it is available. ### The American Herbal Products Association (AHPA) represents the core of the botanical trade -- comprised of the finest growers, processors, manufacturers and marketers of herbal products -- AHPA’s mission is to promote the responsible commerce of herbal products. AHPA committees generate self-regulations to ensure the highest level of quality with respect to the way herbs are manufactured, labeled, and sold. Website: www.ahpa.org.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software